OpenAI’s GPT‑5 cuts protein synthesis cost 40% as AI co‑scientist race heats up after Nobel win

OpenAI's GPT-5 slashed protein synthesis costs by 40%, elevating the AI co-scientist race. This follows Google DeepMind's recent Nobel Prize win for its protein-folding AI, AlphaFold.

Google DeepMind's Demis Hassabis and John Jumper secured the 2024 Nobel Prize in Chemistry. They developed AlphaFold, an artificial intelligence system that accurately predicts complex protein structures, a foundational challenge in biology. This groundbreaking work significantly advanced structural biology and highlighted AI's transformative potential in scientific discovery, moving it beyond data processing to predictive modeling. The prestigious recognition has intensified investment and competition in the rapidly evolving field of AI-driven scientific research globally.

Following this prestigious award, major AI developers accelerate their own scientific initiatives. OpenAI, for instance, openly states building an autonomous researcher as its "North Star" goal. This objective aims for AI systems to not just assist, but to initiate, design, and conduct scientific inquiry with limited human oversight, truly acting as a co-scientist.

OpenAI recently demonstrated a practical step towards this goal by connecting its advanced GPT‑5 model directly to the automated laboratories of Ginkgo Bioworks. This integration allowed the AI system to propose and execute experiments iteratively, a crucial capability for scientific exploration. Crucially, the system also interpreted the experimental results and refined its approach, leading to a 40% reduction in the cost of synthesizing a specific protein. This showcases AI's ability to optimize complex biological processes from hypothesis generation to experimental validation in a feedback loop.

This development signals a significant shift, moving AI beyond data analysis into active, iterative experimental roles within the lab. Such advancements suggest that AI systems could dramatically accelerate discovery across various scientific domains, from materials science to medicine. As AI assumes more autonomous functions, from generating novel hypotheses to conducting iterative experiments and interpreting outcomes, its evolving role in the research pipeline warrants close observation. The race to develop fully autonomous AI co-scientists is now firmly underway, promising to redefine the pace and nature of scientific innovation. Observers will be watching for further breakthroughs in AI's ability to conduct independent research and contribute to solving complex global challenges.